Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics


SAN DIEGO, Oct. 23, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 52 of its Science Bytes podcast, featuring George Wierschem, MBA, MT(ASCP), Senior Global Product Manager – Informatics.

George Wierschem, MBA, MT(ASCP), Senior Global Product Manager – Informatics

In the episode titled "The Power of Informatics in Clinical Decision-Making," Wierschem shares how informatics platforms are transforming laboratory operations by connecting instruments, data systems and clinical decisions. Drawing on over 30 years of laboratory experience, he explains how informatics has evolved from a helpful tool to a critical engine driving lab efficiency, data integrity and patient care.

Key insights include:

  • Insight in an instant: Informatics turns data into decisions
  • Smarter workflows: Automation speeds up results and reduces error
  • Point-of-care confidence: Ensures quality across decentralized testing
  • Built-in security: Cyber-safe systems that don't slow you down
  • Trustworthy data: Tracks every step for full accountability

This episode underscores how informatics is helping labs stay agile, secure and future-ready – especially as demands for speed and accuracy continue to grow.

The QuidelOrtho Science Bytes podcast is available on major streaming platforms and at: https://www.quidelortho.com/global/en/resources/podcasts/quidelortho-science-bytes.

About QuidelOrtho Corporation

With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, delivering fast, accurate and reliable results that help improve patient outcomes – from the point of care to lab, clinic to hospital. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.

Investor Contact: 
Juliet Cunningham
Vice President, Investor Relations
IR@QuidelOrtho.com

Media Contact: 
D. Nikki Wheeler
Senior Director, Corporate Communications
Media@QuidelOrtho.com

QuidelOrtho Science Bytes Episode 52: The Power of Informatics in Clinical Decision-Making

QuidelOrtho Corporation (PRNewsfoto/QuidelOrtho Corporation)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/informatics-illuminated-science-bytes-podcast-explores-the-power-behind-smarter-diagnostics-302593284.html

SOURCE QuidelOrtho Corporation

Werbung

Quidel Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Quidel nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
22.01.18 Quidel Overweight Barclays Capital
18.07.17 Quidel Buy Canaccord Adams
25.04.17 Quidel Hold Canaccord Adams
08.01.16 Quidel Buy Canaccord Adams
02.09.15 Quidel Overweight Barclays Capital

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.